Latest news pravastatin

No rise in renal damage with Stronger statins The Prove It-TIMI 22 is a randomized, double-blind trial of 4,162 patients with acute coronary syndrom...


No rise in renal damage with Stronger statins
The Prove It-TIMI 22 is a randomized, double-blind trial of 4,162 patients with acute coronary syndrome (ACS) who received either 40 mg of pravastatin or atorvastatin 80 mg for the prevention of adverse events (NEJM 2004, 350: 1495-1504) was. Phase Z of the …
Read more on MedPage Today

Leave a Reply